EP4073263A4 - Procédés de formation d'un complexe stable et kits associés - Google Patents

Procédés de formation d'un complexe stable et kits associés Download PDF

Info

Publication number
EP4073263A4
EP4073263A4 EP21737980.9A EP21737980A EP4073263A4 EP 4073263 A4 EP4073263 A4 EP 4073263A4 EP 21737980 A EP21737980 A EP 21737980A EP 4073263 A4 EP4073263 A4 EP 4073263A4
Authority
EP
European Patent Office
Prior art keywords
methods
complex formation
stable complex
related kits
kits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21737980.9A
Other languages
German (de)
English (en)
Other versions
EP4073263A1 (fr
Inventor
Kevin L. GUNDERSON
Norihito MURANAKA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Encodia Inc
Original Assignee
Encodia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Encodia Inc filed Critical Encodia Inc
Priority claimed from PCT/US2021/012224 external-priority patent/WO2021141924A1/fr
Publication of EP4073263A1 publication Critical patent/EP4073263A1/fr
Publication of EP4073263A4 publication Critical patent/EP4073263A4/fr
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B20/00—Methods specially adapted for identifying library members
    • C40B20/04—Identifying library members by means of a tag, label, or other readable or detectable entity associated with the library members, e.g. decoding processes
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B70/00—Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP21737980.9A 2020-01-07 2021-01-05 Procédés de formation d'un complexe stable et kits associés Pending EP4073263A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062958176P 2020-01-07 2020-01-07
PCT/US2021/012224 WO2021141924A1 (fr) 2020-01-07 2021-01-05 Procédés de formation d'un complexe stable et kits associés

Publications (2)

Publication Number Publication Date
EP4073263A1 EP4073263A1 (fr) 2022-10-19
EP4073263A4 true EP4073263A4 (fr) 2023-11-08

Family

ID=76655264

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21737980.9A Pending EP4073263A4 (fr) 2020-01-07 2021-01-05 Procédés de formation d'un complexe stable et kits associés

Country Status (2)

Country Link
US (1) US11169157B2 (fr)
EP (1) EP4073263A4 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4430206A1 (fr) 2021-11-10 2024-09-18 Encodia, Inc. Procédés de codage de macromolécules dans des cellules individuelles
EP4206674A1 (fr) 2021-12-28 2023-07-05 Encodia, Inc. Dosages de sérotypage et de profilage d'anticorps à haut débit

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69931467T3 (de) 1998-11-06 2018-12-27 Lsi Medience Corporation Neue komplexe, die vernetztes avidin enthalten, verfahren zur herstellung und analyseverfahren, das diese verwendet
AU772069B2 (en) 1999-03-23 2004-04-08 Merck Patent Gesellschaft Mit Beschrankter Haftung Protein isolation and analysis
DE602004023960D1 (de) 2003-09-18 2009-12-17 Nuevolution As Methode zur Gewinnung struktureller Informationen kodierter Moleküle und zur Selektion von Verbindungen
WO2007062664A2 (fr) 2005-12-01 2007-06-07 Nuevolution A/S Procedes de codage enzymatique destines a la synthese efficace de bibliotheques importantes
US8642744B2 (en) 2010-10-28 2014-02-04 Agilent Technologies, Inc. Crosslinking reagent for analysis of protein-protein interaction
WO2016164530A1 (fr) 2015-04-07 2016-10-13 University Of Maryland, College Park Compositions et procédés pour le séquençage de protéines à haut débit
US10870872B2 (en) 2016-04-04 2020-12-22 President And Fellows Of Harvard College Enzymatic nucleic acid synthesis
CN110199019B (zh) * 2016-05-02 2024-09-10 Encodia有限公司 采用核酸编码的大分子分析
WO2019089851A1 (fr) 2017-10-31 2019-05-09 Encodia, Inc. Procédés et kits faisant appel au codage et/ou au marquage par acides nucléiques
US20200348307A1 (en) 2017-10-31 2020-11-05 Encodia, Inc. Methods and compositions for polypeptide analysis
EP3704249A4 (fr) 2017-10-31 2021-10-27 Encodia, Inc. Kits d'analyse utilisant un codage et/ou une étiquette d'acide nucléique
MX2020006803A (es) 2017-12-29 2020-10-28 Nautilus Biotechnology Inc Estrategias de descodificacion para identificacion de proteinas.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XING SHUPING ET AL: "Techniques for the Analysis of Protein-Protein Interactions in Vivo", COMPREHENSIVE SEQUENCE ANALYSIS OF 24,783 BARLEY FULL-LENGTH CDNAS DERIVED FROM 12 CLONE LIBRARIES,, vol. 171, no. 2, 1 June 2016 (2016-06-01), pages 727 - 758, XP002761334, ISSN: 1532-2548, [retrieved on 20160425], DOI: 10.?1104/?PP.?16.?00470 *

Also Published As

Publication number Publication date
EP4073263A1 (fr) 2022-10-19
US20210208150A1 (en) 2021-07-08
US11169157B2 (en) 2021-11-09

Similar Documents

Publication Publication Date Title
EP4038178A4 (fr) Compositions nutritives et procédés, kits et compositions cellulaires pour la production de celles-ci
EP4089115A4 (fr) Anticorps anti-tigit et procédé d'utilisation
EP3963070A4 (fr) Procédés de préparation d'analytes et kits associés
EP3947647A4 (fr) Procédés pour la production de cellules nk car et leur utilisation
EP3854819A4 (fr) Nanocellulose et procédé pour la production de celle-ci
EP4031607A4 (fr) Substrats révélables et procédés de production et d'utilisation desdits substrats
EP4073263A4 (fr) Procédés de formation d'un complexe stable et kits associés
EP3973299A4 (fr) Procédés et kits associés pour analyse spatiale
EP3925954A4 (fr) Fluorolactone et procédé de production correspondant
EP3999066A4 (fr) Compositions et kits pour suspension d'oméprazole
EP3938514A4 (fr) Composés et méthodes de réduction de l'expression de kcnt1
AU2022298331A1 (en) Methods
EP4029949A4 (fr) Kit et procédé
EP4026855A4 (fr) Composition et son procédé de production
EP4022041A4 (fr) Lymphocytes t contenant des nef et leurs méthodes de production
EP3922992A4 (fr) Kit destiné à la mesure de substance objet de mesure, et procédé de mesure de substance objet de mesure
EP3911756A4 (fr) Procédés et kits pour le dépistage d'un néoplasme colorectal
EP3980068A4 (fr) Procédés de culture cellulaire et compositions pour la production d'anticorps
EP4013888A4 (fr) Procédés et kits pour diagnostiquer la stérilité
AU2020285524A1 (en) Methods and user interfaces for sharing audio
EP3849557A4 (fr) Kits et méthodes de traitement des cancers
EP4110413A4 (fr) Biomatériaux ainsi que méthodes et kits associés
EP3630684A4 (fr) Séquestrants, kits associés, et procédés d'utilisation de séquestrants et de kits associés
EP4196581A4 (fr) Procédés de codage séquentiel et kits associés
EP4025701A4 (fr) Kits et procédés pour tester des risques de cancer du poumon

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220712

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20231010

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/543 20060101ALI20231004BHEP

Ipc: C40B 70/00 20060101ALI20231004BHEP

Ipc: C40B 20/04 20060101ALI20231004BHEP

Ipc: C12Q 1/6869 20180101ALI20231004BHEP

Ipc: C12Q 1/6811 20180101ALI20231004BHEP

Ipc: C12Q 1/68 20180101AFI20231004BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240827